Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsReceivables - Net
Ratios

Axsome Therapeutics (AXSM) Long-Term Debt Issuances (2023 - 2025)

Axsome Therapeutics (AXSM) has disclosed Long-Term Debt Issuances for 2 consecutive years, with $70.0 million as the latest value for Q4 2025.

  • Quarterly Long-Term Debt Issuances changed N/A to $70.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $140.0 million through Dec 2025, changed N/A year-over-year, with the annual reading at $330.0 million for FY2025, N/A changed from the prior year.
  • Long-Term Debt Issuances hit $70.0 million in Q4 2025 for Axsome Therapeutics, roughly flat from $70.0 million in the prior quarter.
  • In the past five years, Long-Term Debt Issuances ranged from a high of $70.0 million in Q3 2025 to a low of $30.0 million in Q2 2023.